2019年度　論文一覧バックナンバー

【タイトル】

Inotuzumab ozogamicin versus standard of care in Asian patients with
relapsed/refractory acute lymphoblastic leukemia.

【著者名】

Fujishima N, Uchida T, Onishi Y, Jung CW, Goh YT, Ando K, Wang MC, Ono C, 
Matsumizu M, Paccagnella ML, Sleight B, Vandendries E, Fujii Y, Hino M.

【出版物名】

Int J Hematol. 2019; 110(6): 709-722

【タイトル】

Combination of Frailty Status and Comorbidity Score Improves the Stratification of Survival in Patients
With Myelodysplastic Syndrome Owing to Good Predictive Capability for Infection-related Mortality

【著者名】

Sakatoku K, Takeoka Y, Miura A, Araki T, Fujitani Y, Yamamura R, Nakamae H, Ohta K, Hino M.

【出版物名】

Clin Lymphoma Myeloma Leuk. 2019; 19(12): 799-805

【タイトル】

Phase I study of graft-versus-host disease prophylaxis including bortezomib for
allogeneic hematopoietic cell transplantation from unrelated donors with
one or two HLA loci mismatches in Japanese patients.

【著者名】

Nakane T, Okamura H, Tagaito Y, Koh S, Yoshimura T, Makuuchi Y, Nanno S,
Nakamae M, Hirose A, Nakashima Y, Koh H, Hino M, Nakamae H

【出版物名】

Int J Hematol. 2019; 110(6): 736-742

【タイトル】

Cessation of nilotinib in patients with chronic myelogenous leukemia who have maintained
deep molecular responses for 2 years: a multicenter phase 2 trial, stop nilotinib (NILSt).

【著者名】

Nagafuji K, Matsumura I, Shimose T, Kawaguchi T, Kuroda J, Nakamae H, Miyamoto T,
Kadowaki N, Ishikawa J, Imamura Y, Yamazaki H, Akashi K, Kanakura Y

【出版物名】

 Int J Hematol. 2019; 110(6): 675-678

【タイトル】

A prospective observational study of immune reconstitution following transplantation with
post-transplant reduced-dose cyclophosphamide from HLA-haploidentical donors.

【著者名】

Nakamae H, Fujii K, Nanno S, Okamura H, Nakane T, Koh H, Nakashima Y,
Nakamae M, Hirose A, Teshima T, Hino M

【出版物名】

 Transpl Int. 2019; 32(12): 1322-1332

【タイトル】

Different impact of BCR-ABL transcripts on allogeneic hematopoietic cell transplantation from
different graft sources for Ph + ALL with minimal residual disease

【著者名】

Nishiwaki S, Mizuta S, Ohashi K, Fukuda T, Uchida N, Tachibana T, Onizuka M, Ozawa Y,
Onishi Y, Takahashi S, Eto T, Nakamae H, Tanaka J, Ichinohe T, Atsuta Y, Kako S;
Adult Acute Lymphoblastic Leukemia Working Group of the
Japan Society for Hematopoietic Cell Transplantation.

【出版物名】

 Am J Hematol. 2019; 94(11): E301-E305

【タイトル】

Tyrosine kinase inhibitor prophylaxis after transplant for
Philadelphia chromosome-positive acute lymphoblastic leukemia

【著者名】

Akahoshi Y, Nishiwaki S, Mizuta S, Ohashi K, Uchida N, Tanaka M, Fukuda T, Ozawa Y,
Takahashi S, Onizuka M, Shiratori S, Nakamae H, Kanda Y, Ichinohe T, Atsuta Y, Kako S;
Adult Acute Lymphoblastic Leukemia Working Group
of the Japan Society for Hematopoietic Cell Transplantation.

【出版物名】

 Cancer Sci. 2019; 110(10): 3255-3266

【タイトル】

The First Autopsy Case of Fatal Acute Cardiac Failure after
Administration of Carfilzomib in a Patient with Multiple Myeloma

【著者名】

Takakuwa T, Otomaru I, Araki T, Miura A, Fujitani Y, Mochizuki Y, Miyagi Y, Senzaki H, Yamamura R

【出版物名】

 Case Rep Hematol. 2019; 2019: 1816287

【タイトル】

Clinical Impacts of Using Serum IL-6 Level as an Indicator of Cytokine Release Syndrome
after HLA-Haploidentical Transplantation with Post-Transplantation Cyclophosphamide

【著者名】

Nishimoto M, Hirose A, Koh H, Nakamae M, Nanno S, Okamura H, Nakane T,
Nakashima Y, Hino M, Nakamae H

【出版物名】

 Biol Blood Marrow Transplant. 2019; 25(10): 2061-2069

【タイトル】

BM is preferred over PBSCs in transplantation from an HLA-matched related
female donor to a male recipient

【著者名】

Nakasone H, Kawamura K, Yakushijin K, Shinohara A, Tanaka M, Ohashi K, Ota S, Uchida N, Fukuda T,
Nakamae H, Matsuoka KI, Kanda J, Ichinohe T, Atsuta Y, Inamoto Y, Seo S, Kimura F, Ogata M

【出版物名】

 Blood Adv. 2019; 3(11): 1750-1760

【タイトル】

Role of alternative donor allogeneic hematopoietic stem cell transplantation in patients
with intermediate- or poor-risk acute myeloid leukemia in first complete remission

【著者名】

Yano S, Yokoyama H, Yanada M, Mori J, Aoki J, Ohashi K, Kanomori H, Ozawa Y,
Sawa M, Nakamae H, Eto T, Ohta S, Tanaka J, Ichinohe T, Atsuta Y, Takami A.

【出版物名】

 Bone Marrow Transplant. 2019; 54(12): 2004-2012

【タイトル】

Unit selection for umbilical cord blood transplantation for adults with
acute myeloid leukemia in complete remission: a Japanese experience

【著者名】

Yanada M, Konuma T, Kuwatsuka Y, Kondo T, Kawata T, Takahashi S, Uchida N, Miyakoshi S,
Tanaka M, Ozawa Y, Sawa M, Nakamae H, Aotsuka N, Kanda J, Takanashi M, Kanda Y, Atsuta Y, Yano S

【出版物名】

 Bone Marrow Transplant. 2019; 54(11): 1789-1798

【タイトル】

Short-Term Fasting Induces Cell Cycle Arrest in Immature Hematopoietic Cells
and Increases the Number of Naïve T Cells in the Bone Marrow of Mice 

【著者名】

Takakuwa T, Nakashima Y, Koh H, Nakane T, Nakamae H, Hino M

【出版物名】

Acta Haematol. 2019; 141(3): 189-198

【タイトル】

The Proportional Relationship between Pre-transplant WT1 mRNA Levels and Risk of Mortality
after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Not in Remission

【著者名】

Ido K, Nakamae M, Koh H, Okamura H, Nanno S, Nishimoto M, Takeoka Y,
Hirose A, Nakashima Y, Hashimoto Y, Nakane T, Hino M, Nakamae H

【出版物名】

Transplantation. 2019; 103(10): 2201-2210

【タイトル】

Calcium Channel Blockers Possibly Delay the Elimination of Plasma
Methotrexate in Patients Receiving High-Dose Methotrexate Therapy

【著者名】

Inose R, Takahashi K, Nanno S, Hino M, Nagayama K

【出版物名】

J Chemother. 2019; 31(1): 30-34

【タイトル】

Cytomegalovirus reactivation is associated with increased mortality more than 100 days
after allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma

【著者名】

Sawayama Y, Itonaga H, Fukushima T, Nakano N, Fujiwara H, Utsunomiya A, Fukuda T,
Miyamoto T, Eto T, Miyashita K, Nakamae H, Ogata M, Yamanoha A, Miyazaki Y, Kanda J, Atsuta Y, Kato K;
ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation.

【出版物名】

Am J Hematol. 2019; 94(5): E143-E146

【タイトル】

Clinical significance of low-dose total body irradiation in
HLA-mismatched reduced-intensity stem cell transplantation

【著者名】

Fujiwara SI, Kanda J, Tatara R, Ogawa H, Fukuda T, Okumura H, Ohashi K, Iwato K,
Ueda Y, Ishiyama K, Eto T, Matsuoka KI, Nakamae H, Onizuka M, Atsuta Y, Kanda Y;
HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation

【出版物名】

Bone Marrow Transplant. 2019; 54(8): 1327-1336

【タイトル】

Patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation:
trends in survival during the past two decades. 

【著者名】

Yanada M, Masuko M, Mori J, Aoki J, Mizuno S, Fukuda T, Kakihana K, Ozawa Y, Ota S, Kanamori H, Mori T,
Nakamae H, Eto T, Shiratori S, Maeda T, Iwato K, Ichinohe T, Kanda Y, Tanaka J, Atsuta Y, Yano S 

【出版物名】

Bone Marrow Transplant. 2018; 54(4): 578-586

【タイトル】

ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation The outcome and
characteristics of patients with relapsed adult T cell leukemia/lymphoma
after allogeneic hematopoietic stem cell transplantation.

【著者名】

Kato K, Uike N, Wake A, Yoshimitsu M, Tobai T, Sawayama Y, Takatsuka Y, Fukuda T, Uchida N, Eto T,
Nakashima Y, Kondo T, Taguchi J, Miyamoto T, Nakamae H, Ichinohe T, Kato K, Suzuki R, Utsunomiya A;  

【出版物名】

Hematol Oncol. 2019; 37(1): 54-61

【タイトル】

Adult Myelodysplastic Syndrome Working Group of the Japan Society
for Hematopoietic Cell Transplantation.
Induction chemotherapy followed by allogeneic HCT versus
upfront allogeneic HCT for advanced myelodysplastic syndrome: a propensity score matched analysis

【著者名】

Konuma T, Shimomura Y, Ozawa Y, Ueda Y, Uchida N, Onizuka M, Akiyama M, Mori T,
Nakamae H, Ohno Y, Shiratori S, Onishi Y, Kanda Y, Fukuda T, Atsuta Y, Ishiyama K;

【出版物名】

Hematol Oncol. 2019; 37(1): 85-95

【タイトル】

Risk factors and timing of autologous stem cell transplantation for patients with peripheral T-cell lymphoma

【著者名】

Yamasaki S, Chihara D, Kim SW, Kawata T, Mizuta S, Ago H, Chou T, Yamane T, Uchiyama H, Oyake T,
Miura K, Saito B, Taji H, Nakamae H, Miyamoto T, Fukuda T, Kanda J, Atsuta Y, Suzuki R

【出版物名】

Int J Hematol. 2018; 109(2): 175-186

【タイトル】

Impacts of thymoglobulin in patients with acute leukemia in remission
undergoing allogeneic HSCT from different donors

【著者名】

Wakamatsu M, Terakura S, Ohashi K, Fukuda T, Ozawa Y, Kanamori H, Sawa M, Uchida N, Ota S,
Matsushita A, Kanda Y, Nakamae H, Ichinohe T, Kato K, Murata M, Atsuta Y, Teshima T;
GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation

【出版物名】

Blood Adv. 2019; 3(2): 105-115

【タイトル】

Upfront allogeneic HCT vs remission induction chemotherapy followed by allogeneic HCT
for acute myeloid leukemia with multilineage dysplasia: a propensity score matched analysis

【著者名】

Konuma T, Harada K, Yamasaki S, Mizuno S, Uchida N, Takahashi S, Onizuka M, Nakamae H, Hidaka M,
Fukuda T, Ohashi K, Kohno A, Matsushita A, Kanamori H, Ashida T, Kanda J, Atsuta Y, Yano S;
Adult Acute Myeloid Leukemia Working Group of the Japan Society
for Hematopoietic Cell Transplantation

【出版物名】

Am J Hematol. 2018; 94(1): 103-110